QBL now close to start mining bauxite in 2018 - this looks
QBL now close to start mining bauxite in 2018 - this looks like a fantastic year. See latest events; close to signe deals with partners.
MOURILYAN PORT AUTHORITY
On the 10/02/2015, QBL signed an H.O.A. with the Mourilyan Port Authority to ship a minimum of 800,000 tonnes of bauxite per annum from their port facility. The arrangement allows for full utilisation of the port infrastructure including F.O.B. costs. (getting the ore onto the ships)
The Port of Mourilyan is located 15-24klm west, by road, of the South Johnston mine site and has excellent road connections.
Logistics - Transportation/ore processing
The bauxite mineralisation at South Johnstone being close to the surface and right off the main highway adjacent to the port, close to Asian markets, means that the Company's capital and operational costs are estimated to be of the lowest cost producers in the world. As per the Company's released scoping study, capital expenditure is expected to be only approximately $5 million dollars, and operating expenditure is expected to be only AUD$20.87 per tonne FOB Mourilyan Harbour.
ACHIEVEMENTS
* Approval of the MDL
* The DEHP has approved the Environment Authority
* Trial samples (PLURAL) are in international refineries currently being tested and assessed.
* The company has hired a professional mining marketing firm to source and assist in negotiations with large international bauxite customers in Asia.
QBL is ready to move forward as soon as negotiations are formalised and ore samples have been given the green light to be of interest to be processed for offtake by the refineries.
This latest progress is very encouraging - once they get the "go" sign from the refineries, they are fully permitted and ready start mining.
Considering the market for bauxite/aluminum is strong and growing, it will not be long til QBL get revenues from bauxite as well.
Imagine what this will do for the valuation of the company... I think we will see at least a 3-bagger within 2018.
SEE QBL-board on the 3 latest gamechanging posts of 2018!
Here you have the possibility to take advantage on facts and info from QBL. Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up. Contact information to the QBL Investor service, who can reply on questions.
https://www.queenslandbauxite.com/
Read More: https://investorshangout.com/post/view?id=503...z5EvDzLo4L
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...
Continue Reading
A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...
Continue Reading
Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...
Continue Reading
Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...
Continue Reading
Top 5 Most Recently Viewed Articles
Humacyte Inc. Faces Legal Actions from Investors The legal landscape surrounding Humacyte, Inc. has shifted as Kirby McInerney LLP announces a class action lawsuit filed in a U.S. District Court. This action represents investors who acquired shares of Humacyte, Inc. during a specific timeframe. Investors have until a date in early 2025 to seek lead plaintiff status in...
Continue Reading
Sydbank Reports Strong Financial Growth and Strategic Moves In the latest interim report, Sydbank has proudly announced significant profit growth, showcasing strong performance across various sectors. Resilient Earnings Amidst Economic Uncertainty The first three quarters reflect not just growth, but enduring resilience in earnings. Despite the backdrop of macroeconomic...
Continue Reading
Investigating Key Issues Surrounding RLX Technology Inc. In the world of finance, keeping abreast of company developments can often determine the success of investments. One such company currently in the spotlight is RLX Technology Inc. (NYSE: RLX). Recently, concerns have arisen prompting investigations into the company's conduct concerning securities practices. Details...
Continue Reading
Grant Williamson Assumes Role as Canada Leader for WTW In a recent announcement from WTW, a renowned business operating under Nasdaq: WTW, Grant Williamson has been appointed as the Canada leader within the Corporate Risk and Broking (CRB) division. This significant appointment highlights WTW's commitment to expanding its footprint in Canada and reinforcing its leadership...
Continue Reading
Overview of Australia's S&P/ASX 200 Performance Recently, the Australian stock market experienced a noticeable downturn, particularly reflected in the S&P/ASX 200 index which closed down by 0.67%. This movement stemmed from losses across multiple sectors with notable impacts from the Metals & Mining, Materials, and IT sectors. Key Stock Performances on the ASX 200 In the...
Continue Reading